The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1998-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0091-3057(98)00026-4PMID 9632240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action

  2005cited by this paper
• Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine

  2004cited by this paper
• Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats

  2004cited by this paper
• The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm

  1997cited by this paper
• The role of nucleus accumbens subterritories in latent inhibition

  1997cited by this paper
• Latent inhibition in schizophrenia.

  1996cited by this paper
• Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia

  1995cited by this paper
• Rewarding drugs produce taste avoidance, but not taste aversion.

  1995cited by this paper
• Latent inhibition in humans: data, theory, and implications for schizophrenia.

  1995cited by this paper
• Effect of NE-100, a novel sigma receptor ligand, on phencyclidine- induced delayed cognitive dysfunction in rats.

  1995cited by this paper
• The behavior of APO-SUS rats in animal models with construct validity for schizophrenia

  1995cited by this paper
• Effect of phenycyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study

  1994cited by this paper
• Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced cognitive dysfunction.

  1994cited by this paper
• Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

  1994cited by this paper
• Effect of NE-100, a novel σ receptor ligand, on phencyclidine-induced cognitive dysfunction

  1994cited by this paper
• Delayed regional metabolic actions of phencyclidine.

  1993cited by this paper
• Increases in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into the nucleus accumbens.

  1992cited by this paper
• Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.

  1992cited by this paper
• Abolition of latent inhibition by a single 5 mg dose ofd-amphetamine in man

  1992cited by this paper
• The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

  1991cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• Animal models with construct validity for schizophrenia.

  1990cited by this paper
• Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease.

  1990cited by this paper
• Neural substrates of latent inhibition: the switching model.

  1990cited by this paper
• Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

  1989cited by this paper
• Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

  1989cited by this paper
• Disruption of latent inhibition by acute administration of low doses of amphetamine.

  1988cited by this paper
• Differential Performance of Acute and Chronic Schizophrenics in a Latent Inhibition Task

  1988cited by this paper
• Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action

  1988cited by this paper
• Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.

  1987cited by this paper
• Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia.

  1987cited by this paper
• Latent inhibition and schizophrenia

  1987cited by this paper
• Positive and negative symptoms in schizophrenia: attentional performance correlates.

  1986cited by this paper
• Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol.

  1986cited by this paper
• Positive and negative schizophrenic symptoms, attention, and information processing.

  1985cited by this paper
• The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate

  1983cited by this paper
• Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder.

  1981cited by this paper
• Chronic amphetamine and latent inhibition

  1981cited by this paper
• Amphetamine psychosis and psychotic symptoms

  1979cited by this paper
• Phencyclidine-induced psychosis.

  1978cited by this paper
• Latent inhibition.

  1973cited by this paper
• Observations on the psychotomimetic effects of Sernyl.

  1961cited by this paper
• Study of a new schizophrenomimetic drug; sernyl.

  1959cited by this paper

• The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity

  2021cites this paper
• An examination of the roles of glutamate and sex in latent inhibition: Relevance to the glutamate hypothesis of schizophrenia?

  2017cites this paper
• Latent inhibition of a conditioned taste aversion in fetal rats.

  2014cites this paper
• Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats.

  2012cites this paper
• The role of dopamine D2 and neuregulin-1 receptors in schizophrenia relevant phenotypes of cognition, attention and memory

  2012cites this paper
• Effect of the NMDA antagonist MK-801 on latent inhibition of fear conditioning.

  2012cites this paper
• Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.

  2011cites this paper
• Animal Models and Procedures for CNS Disorders

  2010cites this paper
• Interrupción del efecto de inhibición latente por la administración de Mk-801

  2009cites this paper
• Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment.

  2009cites this paper
• Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat

  2008cites this paper
• Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered

  2008cites this paper
• Subchronic phencyclidine exposure potentiates the behavioral and c-Fos response to stressful stimuli in rats.

  2007cites this paper
• Cognitive dysfunction studied in animal models of schizophrenia

  2006cites this paper
• Etude de l'influence de différentes régions télencéphaliques sur la mise en jeu des neurones dopaminergiques mésencéphaliques dans les processus d'inhibition latente

  2006cites this paper
• SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

  2005cites this paper
• Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats

  2005cites this paper
• The effects of phencyclidine on latent inhibition in taste aversion conditioning: differential effects of preexposure and conditioning.

  2005cites this paper
• PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats

  2005cites this paper
• Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion.

  2005cites this paper
• Rolipram attenuates MK-801-induced deficits in latent inhibition.

  2005cites this paper
• Progressive ratio performance following challenge with antipsychotics, amphetamine, or NMDA antagonists in adult rats treated perinatally with phencyclidine

  2004cites this paper
• The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment

  2003influential citation
• Prior exposure to phencyclidine decreases voluntary sucrose consumption and operant performance for food reward.

  2003cites this paper
• Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol

  2003influential citation
• Decreased striatal c-Fos accompanies latent inhibition in a conditioned taste aversion paradigm.

  2002cites this paper
• Behavioral functions of the rat ventral and dorsal hippocampus

  2002cites this paper
• Electrolytic lesions of the medial septum enhance latent inhibition in a conditioned taste aversion paradigm.

  2001cites this paper
• The effects of phencyclidine pretreatment on amphetamine-induced behavior and c-Fos expression in the rat.

  2001cites this paper
• Examination of latent inhibition using shuttle-box avoidance task in rats

  2001cites this paper
• Microinfusion of the non-competitive N-methyl-D-aspartate receptor antagonist MK-801 (dizocilpine) into the dorsal hippocampus of wistar rats does not affect latent inhibition and prepulse inhibition, but increases startle reaction and locomotor activity.

  2000cites this paper
• Atypical Antipsychotics

  2000cites this paper
• The pharmacology of latent inhibition as an animal model of schizophrenia.

  2000cites this paper
• Simulation models for schizophrenia

  2000cites this paper
• Animal models for the negative symptoms of schizophrenia

  2000cites this paper
• The delayed effects of DTG and MK-801 on latent inhibition in a conditioned taste-aversion paradigm.

  2000cites this paper
• MK‐801–induced expression of Fos protein family members in the rat retrosplenial granular cortex

  1999cites this paper
• The delayed effects of phencyclidine enhance amphetamine-induced behavior and striatal C-Fos expression in the rat.

  1999cites this paper